The lawyer Rūta Pumputienė prepared a commentary “Avoiding the repetition of Sicor Biotech’s story” for the business daily Verslo žinios. “The representative of the international generic giant TEVA in Lithuania

The lawyer and Head of the Local American Working Group (LAWG), Rūta Pumputienė, wrote a commentary for the news website DELFI titled “Evaluation of the ambitions and work of the

“Pharmaceutical innovators are facing many obstacles in Lithuania, which need to be addressed by the Ministry of Health and the Government.” “First, the decision making process for including innovative medicines

The Head of the Local American Working Group (LAWG), Rūta Pumputienė, was quoted in the article “Again at the end of the European list: every Lithuanian is angry about it,

The Head of the Local American Working Group (LAWG), Rūta Pumputienė, wrote a commentary for the journal IQ: The Economist about Lithuania’s intentions to become a hub for the Life

The Head of the Local American Working Group (LAWG), Rūta Pumputienė, has written a commentary about the costs of medicine and about how being stingy always means paying twice. It

The Rūta Pumputienė Law Firm was recognised as one of Lithuania’s top legal firms in the areas of biotechnology, information technology and intellectual property law by the Best Lawyer peer

The Head of the Local American Working Group (LAWG), as well as a law partner, Rūta Pumputienė, has analysed the party programmes and identified what changes can be expected in

The lawyer and Head of the Local American Working Group (LAWG), Rūta Pumputienė, wrote a commentary titled “Innovative pharmaceuticals – unfortunately a forgotten area in Lithuania” for the business daily

The book The Life Sciences Law Review has published an overview of the legal issues of interest to pharmaceutical, biotechnology and medical device companies in Lithuania by Rūta Pumputienė and